BioVascular Inc. Closes .87 Million Series C Financing

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service295 times read : Adjust font size: Decrease font Enlarge font
image

Forbes - SAN DIEGO, Feb. 7 /PRNewswire/ -- BioVascular Inc., a company focused on developing therapies targeting platelet-mediated diseases, today announced that it secured .87 Million in Series C financing. The Series C funds will support the clinical ...

Read this article...



Post your comment comment Comments (0 posted)

copyright